nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimozide—CYP2E1—Methimazole—Graves' disease	0.301	0.335	CbGbCtD
Pimozide—CYP2C19—Methimazole—Graves' disease	0.189	0.21	CbGbCtD
Pimozide—CYP1A2—Methimazole—Graves' disease	0.174	0.194	CbGbCtD
Pimozide—CYP2D6—Methimazole—Graves' disease	0.143	0.16	CbGbCtD
Pimozide—CYP3A4—Methimazole—Graves' disease	0.0911	0.102	CbGbCtD
Pimozide—Aplastic anaemia—Methimazole—Graves' disease	0.00516	0.1	CcSEcCtD
Pimozide—Aplastic anaemia—Propylthiouracil—Graves' disease	0.00439	0.085	CcSEcCtD
Pimozide—Drowsiness—Methimazole—Graves' disease	0.00307	0.0596	CcSEcCtD
Pimozide—Agranulocytosis—Methimazole—Graves' disease	0.00287	0.0556	CcSEcCtD
Pimozide—Drowsiness—Propylthiouracil—Graves' disease	0.00261	0.0507	CcSEcCtD
Pimozide—Agranulocytosis—Propylthiouracil—Graves' disease	0.00244	0.0473	CcSEcCtD
Pimozide—Leukopenia—Methimazole—Graves' disease	0.00215	0.0417	CcSEcCtD
Pimozide—Myalgia—Methimazole—Graves' disease	0.00205	0.0396	CcSEcCtD
Pimozide—Leukopenia—Propylthiouracil—Graves' disease	0.00183	0.0354	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00179	0.0346	CcSEcCtD
Pimozide—Somnolence—Methimazole—Graves' disease	0.00174	0.0338	CcSEcCtD
Pimozide—Myalgia—Propylthiouracil—Graves' disease	0.00174	0.0337	CcSEcCtD
Pimozide—Urticaria—Methimazole—Graves' disease	0.00156	0.0302	CcSEcCtD
Pimozide—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00152	0.0294	CcSEcCtD
Pimozide—Somnolence—Propylthiouracil—Graves' disease	0.00148	0.0287	CcSEcCtD
Pimozide—Pruritus—Methimazole—Graves' disease	0.00139	0.0269	CcSEcCtD
Pimozide—Urticaria—Propylthiouracil—Graves' disease	0.00132	0.0257	CcSEcCtD
Pimozide—Vomiting—Methimazole—Graves' disease	0.00125	0.0242	CcSEcCtD
Pimozide—Rash—Methimazole—Graves' disease	0.00124	0.024	CcSEcCtD
Pimozide—Dermatitis—Methimazole—Graves' disease	0.00123	0.0239	CcSEcCtD
Pimozide—Headache—Methimazole—Graves' disease	0.00123	0.0238	CcSEcCtD
Pimozide—Pruritus—Propylthiouracil—Graves' disease	0.00118	0.0229	CcSEcCtD
Pimozide—Nausea—Methimazole—Graves' disease	0.00116	0.0226	CcSEcCtD
Pimozide—Vomiting—Propylthiouracil—Graves' disease	0.00106	0.0205	CcSEcCtD
Pimozide—Rash—Propylthiouracil—Graves' disease	0.00105	0.0204	CcSEcCtD
Pimozide—Dermatitis—Propylthiouracil—Graves' disease	0.00105	0.0204	CcSEcCtD
Pimozide—Headache—Propylthiouracil—Graves' disease	0.00104	0.0202	CcSEcCtD
Pimozide—Nausea—Propylthiouracil—Graves' disease	0.00099	0.0192	CcSEcCtD
Pimozide—ABCB1—Allograft Rejection—IFNG—Graves' disease	8.46e-05	0.00168	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—TSHR—Graves' disease	8.39e-05	0.00166	CbGpPWpGaD
Pimozide—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	8.34e-05	0.00166	CbGpPWpGaD
Pimozide—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	8.07e-05	0.0016	CbGpPWpGaD
Pimozide—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—Graves' disease	8.07e-05	0.0016	CbGpPWpGaD
Pimozide—HTR1A—SIDS Susceptibility Pathways—IL1B—Graves' disease	8.06e-05	0.0016	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—TSHR—Graves' disease	7.92e-05	0.00157	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—TSHR—Graves' disease	7.84e-05	0.00156	CbGpPWpGaD
Pimozide—HTR1A—GPCR ligand binding—CXCL10—Graves' disease	7.82e-05	0.00155	CbGpPWpGaD
Pimozide—ABCB1—Allograft Rejection—IL1B—Graves' disease	7.55e-05	0.0015	CbGpPWpGaD
Pimozide—ABCB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.53e-05	0.00149	CbGpPWpGaD
Pimozide—CALM3—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	7.43e-05	0.00147	CbGpPWpGaD
Pimozide—CALM3—Alzheimers Disease—TNF—Graves' disease	7.23e-05	0.00143	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—TSHR—Graves' disease	7.19e-05	0.00143	CbGpPWpGaD
Pimozide—CALM2—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	7.19e-05	0.00143	CbGpPWpGaD
Pimozide—CALM1—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	7.19e-05	0.00143	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—TSHR—Graves' disease	7.12e-05	0.00141	CbGpPWpGaD
Pimozide—CALM2—Alzheimers Disease—TNF—Graves' disease	6.99e-05	0.00139	CbGpPWpGaD
Pimozide—CALM1—Alzheimers Disease—TNF—Graves' disease	6.99e-05	0.00139	CbGpPWpGaD
Pimozide—HTR2A—SIDS Susceptibility Pathways—IL1B—Graves' disease	6.96e-05	0.00138	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—GC—Graves' disease	6.96e-05	0.00138	CbGpPWpGaD
Pimozide—DRD2—GPCR ligand binding—CXCL10—Graves' disease	6.86e-05	0.00136	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—TSHR—Graves' disease	6.84e-05	0.00136	CbGpPWpGaD
Pimozide—CHRM2—SIDS Susceptibility Pathways—IL1B—Graves' disease	6.84e-05	0.00136	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism of lipids and lipoproteins—GC—Graves' disease	6.8e-05	0.00135	CbGpPWpGaD
Pimozide—HTR2A—GPCR ligand binding—CXCL10—Graves' disease	6.75e-05	0.00134	CbGpPWpGaD
Pimozide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Graves' disease	6.74e-05	0.00134	CbGpPWpGaD
Pimozide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Graves' disease	6.74e-05	0.00134	CbGpPWpGaD
Pimozide—HRH1—GPCR ligand binding—CXCL10—Graves' disease	6.74e-05	0.00134	CbGpPWpGaD
Pimozide—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	6.66e-05	0.00132	CbGpPWpGaD
Pimozide—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—Graves' disease	6.66e-05	0.00132	CbGpPWpGaD
Pimozide—CHRM2—GPCR ligand binding—CXCL10—Graves' disease	6.63e-05	0.00132	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—Graves' disease	6.6e-05	0.00131	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—IFIH1—Graves' disease	6.57e-05	0.0013	CbGpPWpGaD
Pimozide—CACNA1G—Developmental Biology—TNF—Graves' disease	6.45e-05	0.00128	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—Graves' disease	6.37e-05	0.00126	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—IFIH1—Graves' disease	6.35e-05	0.00126	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—IFIH1—Graves' disease	6.35e-05	0.00126	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—TSHR—Graves' disease	6.21e-05	0.00123	CbGpPWpGaD
Pimozide—OPRK1—GPCR downstream signaling—CXCL10—Graves' disease	6.05e-05	0.0012	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—TSHR—Graves' disease	6e-05	0.00119	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—CXCL10—Graves' disease	5.97e-05	0.00118	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—TSHR—Graves' disease	5.91e-05	0.00117	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—TSHR—Graves' disease	5.89e-05	0.00117	CbGpPWpGaD
Pimozide—HTR1A—SIDS Susceptibility Pathways—TNF—Graves' disease	5.85e-05	0.00116	CbGpPWpGaD
Pimozide—CALM3—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	5.81e-05	0.00115	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—TSHR—Graves' disease	5.8e-05	0.00115	CbGpPWpGaD
Pimozide—CALM1—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	5.62e-05	0.00112	CbGpPWpGaD
Pimozide—CALM2—Myometrial Relaxation and Contraction Pathways—IL1B—Graves' disease	5.62e-05	0.00112	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—CXCL10—Graves' disease	5.5e-05	0.00109	CbGpPWpGaD
Pimozide—ABCB1—Allograft Rejection—TNF—Graves' disease	5.48e-05	0.00109	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—TSHR—Graves' disease	5.45e-05	0.00108	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—CXCL10—Graves' disease	5.42e-05	0.00108	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—TSHR—Graves' disease	5.36e-05	0.00106	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—TSHR—Graves' disease	5.35e-05	0.00106	CbGpPWpGaD
Pimozide—CYP3A7—Metabolism—B3GNT2—Graves' disease	5.27e-05	0.00105	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—TSHR—Graves' disease	5.27e-05	0.00104	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—HLA-E—Graves' disease	5.17e-05	0.00103	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—CXCL10—Graves' disease	5.12e-05	0.00102	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—CXCL10—Graves' disease	5.07e-05	0.00101	CbGpPWpGaD
Pimozide—HTR2A—SIDS Susceptibility Pathways—TNF—Graves' disease	5.05e-05	0.001	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—GC—Graves' disease	5.04e-05	0.001	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—GC—Graves' disease	5.03e-05	0.000998	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—TSHR—Graves' disease	5.03e-05	0.000997	CbGpPWpGaD
Pimozide—CALM3—Metabolism—GC—Graves' disease	5.01e-05	0.000994	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—HLA-E—Graves' disease	5e-05	0.000992	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—HLA-E—Graves' disease	5e-05	0.000992	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—HLA-E—Graves' disease	4.96e-05	0.000984	CbGpPWpGaD
Pimozide—CHRM2—SIDS Susceptibility Pathways—TNF—Graves' disease	4.96e-05	0.000984	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—TSHR—Graves' disease	4.95e-05	0.000983	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—CD40—Graves' disease	4.85e-05	0.000962	CbGpPWpGaD
Pimozide—CALM1—Metabolism—GC—Graves' disease	4.84e-05	0.000961	CbGpPWpGaD
Pimozide—CALM2—Metabolism—GC—Graves' disease	4.84e-05	0.000961	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—HLA-E—Graves' disease	4.8e-05	0.000952	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—HLA-E—Graves' disease	4.8e-05	0.000952	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—CTLA4—Graves' disease	4.78e-05	0.000948	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—CD40—Graves' disease	4.69e-05	0.000931	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—CD40—Graves' disease	4.69e-05	0.000931	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—CXCL10—Graves' disease	4.65e-05	0.000922	CbGpPWpGaD
Pimozide—OPRK1—GPCR downstream signaling—IL2RA—Graves' disease	4.63e-05	0.000918	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—CTLA4—Graves' disease	4.62e-05	0.000917	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—CTLA4—Graves' disease	4.62e-05	0.000917	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—CXCL10—Graves' disease	4.6e-05	0.000913	CbGpPWpGaD
Pimozide—HTR6—GPCR downstream signaling—IL2RA—Graves' disease	4.56e-05	0.000905	CbGpPWpGaD
Pimozide—CALM3—Disease—B3GNT2—Graves' disease	4.53e-05	0.000899	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—TSHR—Graves' disease	4.45e-05	0.000883	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—CXCL10—Graves' disease	4.42e-05	0.000876	CbGpPWpGaD
Pimozide—CALM2—Disease—B3GNT2—Graves' disease	4.38e-05	0.00087	CbGpPWpGaD
Pimozide—CALM1—Disease—B3GNT2—Graves' disease	4.38e-05	0.00087	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—TSHR—Graves' disease	4.31e-05	0.000854	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—TSHR—Graves' disease	4.31e-05	0.000854	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—TSHR—Graves' disease	4.25e-05	0.000843	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—TSHR—Graves' disease	4.21e-05	0.000835	CbGpPWpGaD
Pimozide—OPRK1—Signaling by GPCR—IL2RA—Graves' disease	4.2e-05	0.000834	CbGpPWpGaD
Pimozide—HTR6—Signaling by GPCR—IL2RA—Graves' disease	4.14e-05	0.000822	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—CXCL10—Graves' disease	4.01e-05	0.000796	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—HLA-DQB1—Graves' disease	3.93e-05	0.000781	CbGpPWpGaD
Pimozide—OPRM1—GPCR downstream signaling—IL2RA—Graves' disease	3.91e-05	0.000776	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—GC—Graves' disease	3.89e-05	0.000772	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—CXCL10—Graves' disease	3.88e-05	0.00077	CbGpPWpGaD
Pimozide—DRD3—GPCR downstream signaling—IL2RA—Graves' disease	3.87e-05	0.000769	CbGpPWpGaD
Pimozide—CALM3—Hemostasis—IL2RA—Graves' disease	3.83e-05	0.00076	CbGpPWpGaD
Pimozide—CALM3—Immune System—IFIH1—Graves' disease	3.82e-05	0.000759	CbGpPWpGaD
Pimozide—CYP2E1—Metabolism—B3GNT2—Graves' disease	3.82e-05	0.000758	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—CXCL10—Graves' disease	3.82e-05	0.000757	CbGpPWpGaD
Pimozide—CYP3A5—Metabolism—B3GNT2—Graves' disease	3.81e-05	0.000756	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—CXCL10—Graves' disease	3.81e-05	0.000756	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—HLA-DQB1—Graves' disease	3.81e-05	0.000755	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—HLA-DQB1—Graves' disease	3.81e-05	0.000755	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—GC—Graves' disease	3.8e-05	0.000753	CbGpPWpGaD
Pimozide—CALM3—Metabolism—B3GNT2—Graves' disease	3.8e-05	0.000753	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—CXCL10—Graves' disease	3.75e-05	0.000743	CbGpPWpGaD
Pimozide—CALM2—Hemostasis—IL2RA—Graves' disease	3.71e-05	0.000735	CbGpPWpGaD
Pimozide—CALM1—Hemostasis—IL2RA—Graves' disease	3.71e-05	0.000735	CbGpPWpGaD
Pimozide—CALM1—Immune System—IFIH1—Graves' disease	3.7e-05	0.000734	CbGpPWpGaD
Pimozide—CALM2—Immune System—IFIH1—Graves' disease	3.7e-05	0.000734	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—HLA-B—Graves' disease	3.68e-05	0.00073	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—CD8A—Graves' disease	3.67e-05	0.000729	CbGpPWpGaD
Pimozide—CALM2—Metabolism—B3GNT2—Graves' disease	3.67e-05	0.000729	CbGpPWpGaD
Pimozide—CALM1—Metabolism—B3GNT2—Graves' disease	3.67e-05	0.000729	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—TSHR—Graves' disease	3.67e-05	0.000728	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—GC—Graves' disease	3.58e-05	0.00071	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—HLA-B—Graves' disease	3.56e-05	0.000707	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—HLA-B—Graves' disease	3.56e-05	0.000707	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—CD8A—Graves' disease	3.55e-05	0.000705	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—CD8A—Graves' disease	3.55e-05	0.000705	CbGpPWpGaD
Pimozide—OPRM1—Signaling by GPCR—IL2RA—Graves' disease	3.55e-05	0.000705	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—HLA-B—Graves' disease	3.53e-05	0.000701	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—CXCL10—Graves' disease	3.52e-05	0.000699	CbGpPWpGaD
Pimozide—DRD3—Signaling by GPCR—IL2RA—Graves' disease	3.52e-05	0.000698	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—CXCL10—Graves' disease	3.47e-05	0.000688	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—CXCL10—Graves' disease	3.46e-05	0.000686	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—HLA-B—Graves' disease	3.42e-05	0.000678	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—HLA-B—Graves' disease	3.42e-05	0.000678	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—CXCL10—Graves' disease	3.4e-05	0.000675	CbGpPWpGaD
Pimozide—HTR1A—GPCR downstream signaling—IL2RA—Graves' disease	3.38e-05	0.00067	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—HLA-A—Graves' disease	3.27e-05	0.00065	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—CXCL10—Graves' disease	3.25e-05	0.000645	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—TSHR—Graves' disease	3.22e-05	0.000639	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—CXCL10—Graves' disease	3.2e-05	0.000635	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—HLA-A—Graves' disease	3.17e-05	0.000629	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—HLA-A—Graves' disease	3.17e-05	0.000629	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—TSHR—Graves' disease	3.17e-05	0.000629	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—TSHR—Graves' disease	3.16e-05	0.000627	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—TSHR—Graves' disease	3.11e-05	0.000617	CbGpPWpGaD
Pimozide—HTR1A—Signaling by GPCR—IL2RA—Graves' disease	3.07e-05	0.000608	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—GC—Graves' disease	3.03e-05	0.000601	CbGpPWpGaD
Pimozide—CALM3—Immune System—HLA-E—Graves' disease	3.01e-05	0.000597	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—HLA-DRB1—Graves' disease	2.99e-05	0.000594	CbGpPWpGaD
Pimozide—DRD2—GPCR downstream signaling—IL2RA—Graves' disease	2.96e-05	0.000588	CbGpPWpGaD
Pimozide—CYP2C19—Metabolism—B3GNT2—Graves' disease	2.95e-05	0.000585	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD40—Graves' disease	2.94e-05	0.000584	CbGpPWpGaD
Pimozide—HTR2A—GPCR downstream signaling—IL2RA—Graves' disease	2.92e-05	0.000579	CbGpPWpGaD
Pimozide—CALM2—Immune System—HLA-E—Graves' disease	2.91e-05	0.000578	CbGpPWpGaD
Pimozide—CALM1—Immune System—HLA-E—Graves' disease	2.91e-05	0.000578	CbGpPWpGaD
Pimozide—HRH1—GPCR downstream signaling—IL2RA—Graves' disease	2.91e-05	0.000578	CbGpPWpGaD
Pimozide—CALM3—Immune System—CTLA4—Graves' disease	2.9e-05	0.000575	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—HLA-DRB1—Graves' disease	2.89e-05	0.000574	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—HLA-DRB1—Graves' disease	2.89e-05	0.000574	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—CXCL10—Graves' disease	2.88e-05	0.000571	CbGpPWpGaD
Pimozide—ABCB1—Metabolism—B3GNT2—Graves' disease	2.88e-05	0.000571	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—ICAM1—Graves' disease	2.87e-05	0.00057	CbGpPWpGaD
Pimozide—CHRM2—GPCR downstream signaling—IL2RA—Graves' disease	2.86e-05	0.000568	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD40—Graves' disease	2.84e-05	0.000564	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD40—Graves' disease	2.84e-05	0.000564	CbGpPWpGaD
Pimozide—CALM1—Immune System—CTLA4—Graves' disease	2.8e-05	0.000556	CbGpPWpGaD
Pimozide—CALM2—Immune System—CTLA4—Graves' disease	2.8e-05	0.000556	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—CXCL10—Graves' disease	2.78e-05	0.000552	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—CXCL10—Graves' disease	2.78e-05	0.000552	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—ICAM1—Graves' disease	2.78e-05	0.000551	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—ICAM1—Graves' disease	2.78e-05	0.000551	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—CXCL10—Graves' disease	2.75e-05	0.000545	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—CXCL10—Graves' disease	2.72e-05	0.00054	CbGpPWpGaD
Pimozide—CYP2D6—Metabolism—B3GNT2—Graves' disease	2.71e-05	0.000538	CbGpPWpGaD
Pimozide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Graves' disease	2.7e-05	0.000536	CbGpPWpGaD
Pimozide—DRD2—Signaling by GPCR—IL2RA—Graves' disease	2.69e-05	0.000534	CbGpPWpGaD
Pimozide—HTR2A—Signaling by GPCR—IL2RA—Graves' disease	2.65e-05	0.000526	CbGpPWpGaD
Pimozide—HRH1—Signaling by GPCR—IL2RA—Graves' disease	2.64e-05	0.000524	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—TSHR—Graves' disease	2.63e-05	0.000522	CbGpPWpGaD
Pimozide—CHRM2—Signaling by GPCR—IL2RA—Graves' disease	2.6e-05	0.000516	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—TSHR—Graves' disease	2.54e-05	0.000505	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—TSHR—Graves' disease	2.54e-05	0.000505	CbGpPWpGaD
Pimozide—OPRK1—Signaling Pathways—IL2RA—Graves' disease	2.48e-05	0.000493	CbGpPWpGaD
Pimozide—HTR6—Signaling Pathways—IL2RA—Graves' disease	2.45e-05	0.000485	CbGpPWpGaD
Pimozide—CALM3—Immune System—HLA-DQB1—Graves' disease	2.39e-05	0.000474	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—CXCL10—Graves' disease	2.37e-05	0.00047	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—GC—Graves' disease	2.34e-05	0.000464	CbGpPWpGaD
Pimozide—CALM2—Immune System—HLA-DQB1—Graves' disease	2.31e-05	0.000458	CbGpPWpGaD
Pimozide—CALM1—Immune System—HLA-DQB1—Graves' disease	2.31e-05	0.000458	CbGpPWpGaD
Pimozide—CYP1A2—Metabolism—B3GNT2—Graves' disease	2.3e-05	0.000456	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD8A—Graves' disease	2.23e-05	0.000442	CbGpPWpGaD
Pimozide—CALM3—Signaling by GPCR—IL2RA—Graves' disease	2.2e-05	0.000436	CbGpPWpGaD
Pimozide—CALM3—Innate Immune System—CD4—Graves' disease	2.2e-05	0.000436	CbGpPWpGaD
Pimozide—CALM2—Immune System—CD8A—Graves' disease	2.16e-05	0.000428	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD8A—Graves' disease	2.16e-05	0.000428	CbGpPWpGaD
Pimozide—CALM3—Immune System—HLA-B—Graves' disease	2.14e-05	0.000425	CbGpPWpGaD
Pimozide—CALM2—Signaling by GPCR—IL2RA—Graves' disease	2.13e-05	0.000422	CbGpPWpGaD
Pimozide—CALM1—Signaling by GPCR—IL2RA—Graves' disease	2.13e-05	0.000422	CbGpPWpGaD
Pimozide—CALM1—Innate Immune System—CD4—Graves' disease	2.13e-05	0.000422	CbGpPWpGaD
Pimozide—CALM2—Innate Immune System—CD4—Graves' disease	2.13e-05	0.000422	CbGpPWpGaD
Pimozide—CALM3—Adaptive Immune System—CD4—Graves' disease	2.11e-05	0.000419	CbGpPWpGaD
Pimozide—OPRM1—Signaling Pathways—IL2RA—Graves' disease	2.1e-05	0.000416	CbGpPWpGaD
Pimozide—DRD2—Signaling Pathways—CXCL10—Graves' disease	2.08e-05	0.000413	CbGpPWpGaD
Pimozide—DRD3—Signaling Pathways—IL2RA—Graves' disease	2.08e-05	0.000412	CbGpPWpGaD
Pimozide—CALM2—Immune System—HLA-B—Graves' disease	2.07e-05	0.000412	CbGpPWpGaD
Pimozide—CALM1—Immune System—HLA-B—Graves' disease	2.07e-05	0.000412	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—CXCL10—Graves' disease	2.05e-05	0.000406	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—CXCL10—Graves' disease	2.04e-05	0.000405	CbGpPWpGaD
Pimozide—CALM1—Adaptive Immune System—CD4—Graves' disease	2.04e-05	0.000405	CbGpPWpGaD
Pimozide—CALM2—Adaptive Immune System—CD4—Graves' disease	2.04e-05	0.000405	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—CXCL10—Graves' disease	2.01e-05	0.000399	CbGpPWpGaD
Pimozide—CALM3—Immune System—IL2RA—Graves' disease	2.01e-05	0.000399	CbGpPWpGaD
Pimozide—CALM3—Immune System—HLA-A—Graves' disease	1.99e-05	0.000394	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL2RA—Graves' disease	1.94e-05	0.000386	CbGpPWpGaD
Pimozide—CALM1—Immune System—IL2RA—Graves' disease	1.94e-05	0.000386	CbGpPWpGaD
Pimozide—CALM1—Immune System—HLA-A—Graves' disease	1.92e-05	0.000381	CbGpPWpGaD
Pimozide—CALM2—Immune System—HLA-A—Graves' disease	1.92e-05	0.000381	CbGpPWpGaD
Pimozide—CALM3—Disease—HLA-A—Graves' disease	1.83e-05	0.000364	CbGpPWpGaD
Pimozide—CALM3—Immune System—HLA-DRB1—Graves' disease	1.81e-05	0.00036	CbGpPWpGaD
Pimozide—HTR1A—Signaling Pathways—IL2RA—Graves' disease	1.81e-05	0.000359	CbGpPWpGaD
Pimozide—CALM1—Disease—HLA-A—Graves' disease	1.77e-05	0.000352	CbGpPWpGaD
Pimozide—CALM2—Disease—HLA-A—Graves' disease	1.77e-05	0.000352	CbGpPWpGaD
Pimozide—CYP3A4—Metabolism—B3GNT2—Graves' disease	1.77e-05	0.000352	CbGpPWpGaD
Pimozide—CALM2—Immune System—HLA-DRB1—Graves' disease	1.76e-05	0.000348	CbGpPWpGaD
Pimozide—CALM1—Immune System—HLA-DRB1—Graves' disease	1.76e-05	0.000348	CbGpPWpGaD
Pimozide—CALM3—Immune System—ICAM1—Graves' disease	1.74e-05	0.000346	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—CXCL10—Graves' disease	1.7e-05	0.000337	CbGpPWpGaD
Pimozide—CALM2—Immune System—ICAM1—Graves' disease	1.68e-05	0.000334	CbGpPWpGaD
Pimozide—CALM1—Immune System—ICAM1—Graves' disease	1.68e-05	0.000334	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—CXCL10—Graves' disease	1.64e-05	0.000326	CbGpPWpGaD
Pimozide—CALM1—Signaling Pathways—CXCL10—Graves' disease	1.64e-05	0.000326	CbGpPWpGaD
Pimozide—CALM3—eye—Graves' disease	1.6e-05	0.0626	CbGeAlD
Pimozide—DRD2—Signaling Pathways—IL2RA—Graves' disease	1.59e-05	0.000316	CbGpPWpGaD
Pimozide—HTR2A—Signaling Pathways—IL2RA—Graves' disease	1.56e-05	0.00031	CbGpPWpGaD
Pimozide—HRH1—Signaling Pathways—IL2RA—Graves' disease	1.56e-05	0.00031	CbGpPWpGaD
Pimozide—CHRM2—Signaling Pathways—IL2RA—Graves' disease	1.54e-05	0.000305	CbGpPWpGaD
Pimozide—CALM3—Immune System—IFNG—Graves' disease	1.33e-05	0.000263	CbGpPWpGaD
Pimozide—CALM3—Signaling Pathways—IL2RA—Graves' disease	1.3e-05	0.000258	CbGpPWpGaD
Pimozide—CALM1—Immune System—IFNG—Graves' disease	1.28e-05	0.000254	CbGpPWpGaD
Pimozide—CALM2—Immune System—IFNG—Graves' disease	1.28e-05	0.000254	CbGpPWpGaD
Pimozide—CALM3—Immune System—CD4—Graves' disease	1.28e-05	0.000254	CbGpPWpGaD
Pimozide—CALM2—eye—Graves' disease	1.26e-05	0.0492	CbGeAlD
Pimozide—CALM1—Signaling Pathways—IL2RA—Graves' disease	1.26e-05	0.000249	CbGpPWpGaD
Pimozide—CALM2—Signaling Pathways—IL2RA—Graves' disease	1.26e-05	0.000249	CbGpPWpGaD
Pimozide—CALM1—eye—Graves' disease	1.25e-05	0.0489	CbGeAlD
Pimozide—CALM2—Immune System—CD4—Graves' disease	1.24e-05	0.000246	CbGpPWpGaD
Pimozide—CALM1—Immune System—CD4—Graves' disease	1.24e-05	0.000246	CbGpPWpGaD
Pimozide—CALM2—connective tissue—Graves' disease	1.21e-05	0.0474	CbGeAlD
Pimozide—CALM1—connective tissue—Graves' disease	1.21e-05	0.0471	CbGeAlD
Pimozide—CALM3—pituitary gland—Graves' disease	1.19e-05	0.0465	CbGeAlD
Pimozide—CALM3—adipose tissue—Graves' disease	1.18e-05	0.0463	CbGeAlD
Pimozide—CALM3—Immune System—IL1B—Graves' disease	1.18e-05	0.000235	CbGpPWpGaD
Pimozide—CALM3—Disease—CD4—Graves' disease	1.18e-05	0.000235	CbGpPWpGaD
Pimozide—DRD2—eye—Graves' disease	1.16e-05	0.0452	CbGeAlD
Pimozide—CALM1—Immune System—IL1B—Graves' disease	1.14e-05	0.000227	CbGpPWpGaD
Pimozide—CALM2—Immune System—IL1B—Graves' disease	1.14e-05	0.000227	CbGpPWpGaD
Pimozide—CALM2—Disease—CD4—Graves' disease	1.14e-05	0.000227	CbGpPWpGaD
Pimozide—CALM1—Disease—CD4—Graves' disease	1.14e-05	0.000227	CbGpPWpGaD
Pimozide—CALM3—thyroid gland—Graves' disease	1.02e-05	0.04	CbGeAlD
Pimozide—CALM2—pituitary gland—Graves' disease	9.33e-06	0.0365	CbGeAlD
Pimozide—CALM2—adipose tissue—Graves' disease	9.29e-06	0.0363	CbGeAlD
Pimozide—CALM1—pituitary gland—Graves' disease	9.29e-06	0.0363	CbGeAlD
Pimozide—CALM1—adipose tissue—Graves' disease	9.25e-06	0.0362	CbGeAlD
Pimozide—HRH1—eye—Graves' disease	9.13e-06	0.0357	CbGeAlD
Pimozide—HRH1—connective tissue—Graves' disease	8.79e-06	0.0344	CbGeAlD
Pimozide—DRD2—pituitary gland—Graves' disease	8.58e-06	0.0335	CbGeAlD
Pimozide—KCNH2—pituitary gland—Graves' disease	8.45e-06	0.033	CbGeAlD
Pimozide—CALM2—thyroid gland—Graves' disease	8.04e-06	0.0315	CbGeAlD
Pimozide—CALM1—thyroid gland—Graves' disease	8.01e-06	0.0313	CbGeAlD
Pimozide—HTR2A—eye—Graves' disease	7.62e-06	0.0298	CbGeAlD
Pimozide—HTR2A—connective tissue—Graves' disease	7.34e-06	0.0287	CbGeAlD
Pimozide—CYP3A5—adipose tissue—Graves' disease	6.95e-06	0.0272	CbGeAlD
Pimozide—HRH1—adipose tissue—Graves' disease	6.75e-06	0.0264	CbGeAlD
Pimozide—CYP1A2—thyroid gland—Graves' disease	6.24e-06	0.0244	CbGeAlD
Pimozide—HTR2A—pituitary gland—Graves' disease	5.66e-06	0.0221	CbGeAlD
Pimozide—CYP2E1—thyroid gland—Graves' disease	5.61e-06	0.0219	CbGeAlD
Pimozide—ABCB1—pituitary gland—Graves' disease	3.71e-06	0.0145	CbGeAlD
Pimozide—ABCB1—adipose tissue—Graves' disease	3.69e-06	0.0144	CbGeAlD
Pimozide—ABCB1—thyroid gland—Graves' disease	3.2e-06	0.0125	CbGeAlD
